Literature DB >> 24131031

Evaluation of MDI-spacer utilization and technique in caregivers of urban minority children with persistent asthma.

Marina Reznik1, Ellen Johnson Silver, Yu Cao.   

Abstract

OBJECTIVE: Incorrect Metered-Dose Inhaler (MDI)-spacer technique can result in decreased drug delivery to distal airways and poor asthma outcomes. There is lack of research to examine whether the caregivers utilize proper technique when applying an MDI-spacer delivery system for young minority children with persistent asthma in the United States. The objective of this study was to evaluate MDI-spacer utilization and technique among the caregivers of Bronx minority children with persistent asthma and to determine characteristics associated with correct use.
METHODS: We analyzed data from 169 caregivers of urban minority children with persistent asthma (aged 2-9 years). MDI-spacer device technique was assessed using a 10-step checklist derived from the national guidelines, literature and manufacturers' instructions. Based on the median MDI-technique score of six steps demonstrated accurately, caregivers were categorized as correct (seven or more) or incorrect (six or less) users.
RESULTS: Of the 169 caregivers, 95% were mothers, mean age 32.3 years (SD 7.6), 56% were unemployed; 74% of the children were Hispanic, 87% had either "not well controlled" or "very poorly controlled" asthma, 92% had a spacer at home and 71% used it "all" or "most" of the time. Only one caregiver correctly demonstrated all 10 steps of the MDI-spacer technique. Child's having one or more asthma-related hospitalizations in the past 12 months and higher caregiver educational level were independent predictors of correct MDI-spacer technique. CONCLUSIONS AND RELEVANCE: The caregivers of urban, minority children with persistent asthma lack proper MDI-spacer technique, suggesting the potential value of both targeted short- and long-term educational interventions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24131031     DOI: 10.3109/02770903.2013.854379

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  7 in total

Review 1.  Severe asthma in school-age children: evaluation and phenotypic advances.

Authors:  Andrea Coverstone; Leonard B Bacharier; Anne M Fitzpatrick
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 2.  A systematic review of instruments aimed at evaluating metered-dose inhaler administration technique in children.

Authors:  Carlos E Rodríguez-Martínez; Monica P Sossa-Briceño; Gustavo Nino
Journal:  J Asthma       Date:  2016-06-15       Impact factor: 2.515

3.  What Really Happens in the Home: The Medication Environment of Urban, Minority Youth.

Authors:  Andrea A Pappalardo; Kelly Karavolos; Molly A Martin
Journal:  J Allergy Clin Immunol Pract       Date:  2016-11-30

4.  Are children with asthma overconfident that they are using their inhalers correctly?

Authors:  Dayna S Alexander; Lorie Geryk; Courtney Arrindell; Darren A DeWalt; Mark A Weaver; Betsy Sleath; Delesha M Carpenter
Journal:  J Asthma       Date:  2015-09-14       Impact factor: 2.515

Review 5.  School-based supervised therapy programs to improve asthma outcomes: current perspectives.

Authors:  Guadalupe Salazar; Geeta Tarwala; Marina Reznik
Journal:  J Asthma Allergy       Date:  2018-08-29

6.  Comparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthma.

Authors:  Simon Wan Yau Ming; John Haughney; Dermot Ryan; Shishir Patel; Matthias Ochel; Martina Stagno d'Alcontres; Susannah Thornhill; Janwillem W H Kocks; David Price
Journal:  NPJ Prim Care Respir Med       Date:  2019-02-08       Impact factor: 2.871

7.  Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma.

Authors:  Gordon Raphael; Herminia Taveras; Harald Iverson; Christopher O'Brien; David Miller
Journal:  J Asthma       Date:  2015-09-15       Impact factor: 2.515

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.